Tempus AI

33 atoms · 跨 10 天 · 首见 2026-04-15 · 最近 2026-07-02

三色: 🟦 fact 30 · 🟥 take 3 · stance ▲11/▼0/◆17

叙事状态: 🍂 fading (退潮) · 💤 沉寂 · 策展近14d 0 atom · 🐦 X 近14d 3

状态只算低频策展源 (群/卖方); X firehose 仅作背景音量

来源: X 33

时态: fresh:31 · stale:2

标签: 好信源:19 · 好数字:12 · 好观点:7 · 好思考:1

🟨 AI 综合 · junior analyst 概览

🟦 客观事实 (facts) (29)

• <a id="atom-c77a5c780c72de97"></a>🟦 2026-06-25 X·@AIStockSavvy · 该数据集是已知最大血管肉瘤分子资源之一 · 供给产能
  The dataset represents one of the largest known molecular resources for angiosarcoma.
  tags: 好数字·好信源 · → daily
• <a id="atom-ff6026f71c42218c"></a>🟦 2026-06-25 X·@AIStockSavvy · CMO Ezra Cohen陈述：罕见癌症精准医学不应受数据限制 · 管理层表态
  Precision medicine should not be limited by the availability of data, especially for patients with uncommon and aggressive cancers. — Ezra Cohen, MD, Chief Medical Officer of Oncology at Tempus.
  tags: 好观点·好信源 · → daily
• <a id="atom-dfa775ab07d2ff69"></a>🟦 2026-06-25 X·@AIStockSavvy · CMO Ezra Cohen陈述：合作可兑现精准医学承诺 · 管理层表态
  By bringing together Tempus' multimodal molecular and clinical data with collaborative research efforts across the healthcare community, we can fulfill the promise of precision medicine by treating the right patient with the right therapy at the right time. — Ezra Cohen, MD
  tags: 好观点·好信源 · → daily
• <a id="atom-b485ceb255b67d27"></a>🟦 2026-06-25 X·@AIStockSavvy · Angiosarcoma Awareness CEO Corrie Painter陈述：罕见癌症研究长期受规模限制 · 管理层表态
  Rare cancer research has long been constrained by scale. Patients are geographically dispersed, data is fragmented across institutions and no single organization sees enough cases to answer many of the most important biological and clinical questions. — Corrie Painter, CEO of Angiosarcoma Awareness, Inc
  tags: 好观点·好信源 · → daily
• <a id="atom-9740fb2a7e159bcd"></a>🟦 2026-06-25 X·@AIStockSavvy · Angiosarcoma Awareness CEO Corrie Painter陈述：合作可揭示新疾病生物学 · 管理层表态
  Together, we have an opportunity to create an unprecedented view of angiosarcoma that could reveal new disease biology, identify therapeutic opportunities and establish a model for how collaborative data sharing can accelerate discovery across rare cancers. — Corrie Painter
  tags: 好观点·好信源 · → daily
• <a id="atom-2708e1175088c2d8"></a>🟦 2026-06-03 X·@AIStockSavvy · 与Yale和MSK合作推出IMS联盟 · 合作客户
  Tempus AI, Yale, and MSK Launch Open-Source Digital Pathology Consortium
  tags: 好信源 · → daily
• <a id="atom-11509c6636894db4"></a>🟦 2026-06-03 X·@AIStockSavvy · 将开源Paige IMS平台 · 产品发布
  Tempus will open source the Paige IMS platform and key modules.
  tags: 好信源 · → daily
• <a id="atom-645cdb6b9b18a8c4"></a>🟦 2026-06-03 X·@AIStockSavvy · SVP和GM of AI Products表态病理学进入新时代 · 管理层表态
  'Pathology is entering a transformative new era,' said Razik Yousfi, SVP and GM of AI Products at Tempus.
  tags: 好信源 · → daily
• <a id="atom-e706f3240000fe24"></a>🟦 2026-06-01 X·@AIStockSavvy · 推出全基因组癌症检测 · 产品发布
  Tempus AI announces clinical availability of xH, a whole-genome sequencing cancer test.
  tags: 好信源 · → daily
  value: date=2026-06-01
• <a id="atom-06539f6f9fc51c0e"></a>🟦 2026-05-06 X·@AIStockSavvy [老旧] · TD Cowen 目标价 · 评级目标价
  raises PT to $68
  tags: 好数字 · → daily
  value: qty=$68 · direction=上调
  [图: TD Cowen对Tempus AI (TEM) 的分析师评级与目标价更新摘要表 — 新目标价 (Price Target): $68.00; 当前股价 (Current Price): $54.07; 潜在上涨空间 (Upside): +25.8%; 第一季度销售额增长 (1Q sales growth): +36%; 目标价上调幅度 (Chang
  📷 原图
• <a id="atom-8f62b34d5c715470"></a>🟦 2026-06-25 X·@AIStockSavvy · 血管肉瘤数据集包含约600条去识别记录 · 出货量
  Dataset includes approximately 600 de-identified angiosarcoma patient records.
  tags: 好数字 · → daily
  value: qty=600条
• <a id="atom-7445d89fc42b64f1"></a>🟦 2026-06-25 X·@AIStockSavvy · 美国每年约1000人受血管肉瘤影响 · TAM
  Angiosarcoma affects about 1,000 people annually in the United States.
  tags: 好数字 · → daily
  value: qty=1000人 · date=每年
• <a id="atom-f772fced5ef8a48c"></a>🟦 2026-05-31 X·@AIStockSavvy · Supports analysis across 8.5M+ de-identified patient records · 数据规模
  tags: 好数字 · → daily
  value: qty=8.5M+
• <a id="atom-11b9997dcb1677d7"></a>🟦 2026-05-31 X·@AIStockSavvy · Already utilized by 19 of top 20 global biopharma companies · 合作客户
  tags: 好数字 · → daily
  value: qty=19 of top 20
• <a id="atom-bee96d100238b4c8"></a>🟦 2026-05-30 X·@AIStockSavvy · Tempus Preview 交付初始生物标志物见解时间 · 产品发布
  Application delivers preliminary biomarker insights within ~𝟐𝟒 𝐡𝐨𝐮𝐫𝐬 of tissue receipt.
  tags: 好数字 · → daily
  value: qty=~24 小时 · date=收到组织后
• <a id="atom-a3ee20a14d1a5ca5"></a>🟦 2026-05-06 X·@AIStockSavvy [老旧] · TD Cowen 评级 · 评级目标价
  TD Cowen maintains Buy
  tags: 好信源 · → daily
  value: direction=Buy
  [图: TD Cowen对Tempus AI (TEM) 的分析师评级与目标价更新摘要表 — 新目标价 (Price Target): $68.00; 当前股价 (Current Price): $54.07; 潜在上涨空间 (Upside): +25.8%; 第一季度销售额增长 (1Q sales growth): +36%; 目标价上调幅度 (Chang
  📷 原图
• <a id="atom-d27a4ea87a4f322e"></a>🟦 2026-05-06 X·@AIStockSavvy · 潜在上涨空间 · 评级目标价
  潜在上涨空间 +25.8%
  tags: 好数字 · → daily
  value: qty=+25.8%
  [图: TD Cowen对Tempus AI (TEM) 的分析师评级与目标价更新摘要表 — 新目标价 (Price Target): $68.00; 当前股价 (Current Price): $54.07; 潜在上涨空间 (Upside): +25.8%; 第一季度销售额增长 (1Q sales growth): +36%; 目标价上调幅度 (Chang
  📷 原图
• <a id="atom-0c42caf212176cdd"></a>🟦 2026-05-06 X·@AIStockSavvy · 第一季度销售额增长 · 营收
  第一季度销售额增长 +36%
  tags: 好数字 · → daily
  value: qty=+36%
  [图: TD Cowen对Tempus AI (TEM) 的分析师评级与目标价更新摘要表 — 新目标价 (Price Target): $68.00; 当前股价 (Current Price): $54.07; 潜在上涨空间 (Upside): +25.8%; 第一季度销售额增长 (1Q sales growth): +36%; 目标价上调幅度 (Chang
  📷 原图
• <a id="atom-352940347b92a358"></a>🟦 2026-04-15 X·@AIStockSavvy · GenoPredicta assay launch · 产品发布
  Tempus AI partners with Predicta to launch GenoPredicta assay.
  tags: 好数字 · → daily
• <a id="atom-30463a9032214307"></a>🟦 2026-06-25 X·@AIStockSavvy · 与Angiosarcoma Awareness合作 · 合作客户
  Tempus AI partnered with Angiosarcoma Awareness to accelerate rare cancer research.
  tags: 好信源 · → daily
• <a id="atom-ed9681c15c665bf9"></a>🟦 2026-06-25 X·@AIStockSavvy · 分子临床AI分析能力将用于合作 · 技术路线
  Collaboration will leverage Tempus' molecular, clinical, and AI analytics capabilities.
  tags: 好信源 · → daily
• <a id="atom-c651eee369aac8f7"></a>🟦 2026-06-25 X·@AIStockSavvy · 每条记录包含配对DNA和RNA测序数据 · 技术路线
  Each record contains paired DNA and RNA sequencing data with clinical information where available.
  tags: 好信源 · → daily
• <a id="atom-f684c2f7e05d4bf1"></a>🟦 2026-06-25 X·@AIStockSavvy · 研究旨在识别疾病生物学和治疗机会 · 技术路线
  Research aims to identify disease biology and potential therapeutic opportunities.
  tags: 好信源 · → daily
• <a id="atom-1b05c257a6381975"></a>🟦 2026-06-25 X·@AIStockSavvy · 合作基于2017年启动的Angiosarcoma Project · 合作客户
  Collaboration builds on the Angiosarcoma Project launched in 2017.
  tags: 好信源 · → daily
• <a id="atom-64273816172a16ef"></a>🟦 2026-05-30 X·@AIStockSavvy · 推出 Tempus Preview · 产品发布
  Tempus AI unveils 𝐓𝐞𝐦𝐩𝐮𝐬 𝐏𝐫𝐞𝐯𝐢𝐞𝐰 for rapid oncology decision support.
  tags: 好信源 · → daily
• <a id="atom-89b20104088efd05"></a>🟦 2026-05-30 X·@AIStockSavvy · 初始关注突变类型 · 技术路线
  Initial focus includes 𝐌𝐒𝐈-𝐇, 𝐄𝐆𝐅𝐑 mutations, and 𝐅𝐆𝐅𝐑 fusions.
  tags: 好信源 · → daily
• <a id="atom-c5b2f5ec0eb5c476"></a>🟦 2026-05-30 X·@AIStockSavvy · 预测由 Paige Predict AI 驱动 · 技术路线
  Predictions powered by 𝐏𝐚𝐢𝐠𝐞 𝐏𝐫𝐞𝐝𝐢𝐜𝐭 AI trained on millions of slides.
  tags: 好信源 · → daily
• <a id="atom-931b1deace5546da"></a>🟦 2026-04-15 X·@AIStockSavvy · validated for multiple myeloma · 产品发布
  Validated for multiple myeloma and plasma cell disorders.
  tags: 好信源 · → daily
• <a id="atom-6fe2a0de3bd9b875"></a>🟦 2026-05-31 X·@AIStockSavvy · Platform integrates multimodal data, AI agents, and scientific workflows · 技术路线
  tags: 好思考 · → daily

🟥 多头 takes (bullish) (1)

• <a id="atom-7121050fadca0384"></a>🟥 2026-06-04 X·@Xgngu12 · strong rebound after long suppression · 价格动态/生物科技
  템퍼스 AI, 힘즈 오랫동안 눌려왔었는데 오늘 강한 반등을 보여주고 있구요.
  tags: 好观点 · → daily
  📷 原图

🟥 中性 takes (neutral) (2)

• <a id="atom-100ff2f67933dd71"></a>🟥 2026-06-30 X·@AIStockSavvy · 目标价 · 评级目标价
  Freedom Capital initiates coverage on Tempus AI Inc with Hold, PT at $59.00
  tags: 好数字·好观点 · → daily
  value: qty=$59.00 · date=2026-06-30
  📷 原图
• <a id="atom-b584dc2e49246df0"></a>🟥 2026-06-30 X·@AIStockSavvy · 评级 · 评级目标价
  Freedom Capital initiates coverage on Tempus AI Inc with Hold, PT at $59.00
  tags: 好观点 · → daily
  value: qty=Hold · date=2026-06-30
  📷 原图

🟦 新闻流 (squawk · 1)

⏱ 时间轴 (近 20)

• 🟦 2026-07-02 · fact · return since fund inception · → daily
• 🟥 2026-06-30 · position · 评级 · → daily
• 🟥 2026-06-30 · position · 目标价 · → daily
• 🟦 2026-06-25 · fact · 与Angiosarcoma Awareness合作 · → daily
• 🟦 2026-06-25 · fact · 分子临床AI分析能力将用于合作 · → daily
• 🟦 2026-06-25 · fact · 血管肉瘤数据集包含约600条去识别记录 · → daily
• 🟦 2026-06-25 · fact · 每条记录包含配对DNA和RNA测序数据 · → daily
• 🟦 2026-06-25 · fact · 该数据集是已知最大血管肉瘤分子资源之一 · → daily
• 🟦 2026-06-25 · fact · 美国每年约1000人受血管肉瘤影响 · → daily
• 🟦 2026-06-25 · fact · 研究旨在识别疾病生物学和治疗机会 · → daily
• 🟦 2026-06-25 · fact · 合作基于2017年启动的Angiosarcoma Project · → daily
• 🟦 2026-06-25 · fact · CMO Ezra Cohen陈述：罕见癌症精准医学不应受数据限制 · → daily
• 🟦 2026-06-25 · fact · CMO Ezra Cohen陈述：合作可兑现精准医学承诺 · → daily
• 🟦 2026-06-25 · fact · Angiosarcoma Awareness CEO Corrie Painter陈述：罕见癌症研究长期受规模限制 · → daily
• 🟦 2026-06-25 · fact · Angiosarcoma Awareness CEO Corrie Painter陈述：合作可揭示新疾病生物学 · → daily
• 🟥 2026-06-04 · fact · strong rebound after long suppression · → daily
• 🟦 2026-06-03 · fact · 与Yale和MSK合作推出IMS联盟 · → daily
• 🟦 2026-06-03 · fact · 将开源Paige IMS平台 · → daily
• 🟦 2026-06-03 · fact · SVP和GM of AI Products表态病理学进入新时代 · → daily
• 🟦 2026-06-01 · fact · 推出全基因组癌症检测 · → daily

← 实体目录 · 系统日志